MuirC. The cancer burden with special reference to Europe and the EC countries. In HellerTDaveyBBaileyL, eds. Reducing the risk of cancers. London: Hodder and Stoughton, The Open University, 1989.
2.
World Health Organisation. Targets for health for all. Copenhagen: WHO Regional Office for Europe, 1985.
3.
BrownM. The national economic burden of cancer: An update. Journal of the National Cancer Institute1990;82: 1811–1814.
4.
BlackDPoleJ. Priorities in biomedical research: Indices of burden. British Journal of Preventive and Social Medicine1975;29: 222–227.
5.
Office of Population Censuses and Surveys. Mortality statistics: Cause 1991. London: HMSO, 1993.
6.
YoungD. Modificanon in dietary habits and cancer prevention: Better than cure?Journal of Managed Care1997;1: 76–82.
7.
Department of Health. Policy appraisal and health. London: HMSO, 1995.
8.
DrummondMMcGuireABlackNPetticrewMMcPhersonK. Economic burden of treated benign prostatic hyperplasia in the UK. British Journal of Urology1993;71: 290–296.
9.
McMurrayJ. An evaluation of the cost of heart failure to the National Health Service in the UK. British Journal of Medical Economics1993;6: 99–110.
10.
GerardKDonaldsonCMaynardA. The cost of diabetes. Diabetic Medicine1989;6: 164–170.
11.
SmithKShahAWrightKLewisG. The prevalence and costs of psychiatric disorders and learning disabilities. British Journal of Psychiatry1995;166: 9–18.
12.
Prostate cancer: ‘watch and wait’. Health Service Journal1997;/107(5540)/6.
13.
BryanSParkinDDonaldsonC. Chiropody and the QALY: A case study in assigning categories of disability and distress to patients. Health Policy1991;18169–85.
14.
BirchSGafhiA. Cost-effectiveness ratios: In a league of their own. Health Policy1994;28: 133–141.
15.
DonaldsonCWalkerACraigN. Programme budgeting and marginal analysis. Scotland: Scottish Forum for Public Health Medicine, 1995.
